First patient consents to lymphoma trial

Norton Cancer Institute has enlisted the first patient ever to participate in a clinical trial studying a potential new drug to treat a type of rare lymphoma. The female patient will receive a drug designed […]

View more

Refractory epilepsy treatments available

Patients with refractory epilepsy face a greater risk of accidents, injuries, cognitive issues, mood disorders, social difficulties and unemployment. Norton Neuroscience Institute offers a variety of treatments that can vastly improve quality of life for these patients, […]

View more

Search our entire site.